Psychedelics not linked to mental health problems or suicidal behavior: a population study

Journal of Psychopharmacology
Pål-Ørjan Johansen, Teri S Krebs

Abstract

A recent large population study of 130,000 adults in the United States failed to find evidence for a link between psychedelic use (lysergic acid diethylamide, psilocybin or mescaline) and mental health problems. Using a new data set consisting of 135,095 randomly selected United States adults, including 19,299 psychedelic users, we examine the associations between psychedelic use and mental health. After adjusting for sociodemographics, other drug use and childhood depression, we found no significant associations between lifetime use of psychedelics and increased likelihood of past year serious psychological distress, mental health treatment, suicidal thoughts, suicidal plans and suicide attempt, depression and anxiety. We failed to find evidence that psychedelic use is an independent risk factor for mental health problems. Psychedelics are not known to harm the brain or other body organs or to cause addiction or compulsive use; serious adverse events involving psychedelics are extremely rare. Overall, it is difficult to see how prohibition of psychedelics can be justified as a public health measure.

References

Jun 1, 1973·Psychological Bulletin·S A McWilliams, R J Tuttle
Feb 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·N Malleson
Jan 1, 1971·Archives of General Psychiatry·W H McGlothlin, D O Arnold
Jun 5, 2002·Lancet·Jan G BruhnOlof Beck
Oct 11, 2002·Suicide & Life-threatening Behavior·Thomas M KellyKevin G Lynch
Feb 13, 2003·Archives of General Psychiatry·Ronald C KesslerAlan M Zaslavsky
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jan 1, 1959·Maryland State Medical Journal·I D YALOM
Jan 1, 1960·The Journal of Nervous and Mental Disease·S COHEN
Nov 8, 2005·Biological Psychiatry·John H HalpernHarrison G Pope
Dec 22, 2006·American Journal of Epidemiology·Eric Vittinghoff, Charles E McCulloch
Jan 5, 2007·Journal of Child and Adolescent Psychopharmacology·Gal ShovalGil Zalsman
May 2, 1952·Science·J Collier
Nov 30, 1951·Science·W LA BarreS Tax
Jul 3, 2008·Journal of Psychopharmacology·Mw JohnsonRr Griffiths
Nov 27, 2009·Journal of Psychopharmacology·Celia J A MorganH Valerie Curran
Jul 8, 2010·European Addiction Research·Jan van AmsterdamWim van den Brink
Nov 3, 2010·Lancet·David J NuttUNKNOWN Independent Scientific Committee on Drugs
Jun 16, 2011·Psychopharmacology·Roland R GriffithsRobert Jesse
Oct 1, 2011·Journal of Psychopharmacology·Katherine A MacLeanRoland R Griffiths
Mar 13, 2012·Journal of Psychopharmacology·Teri S Krebs, Pål-Ørjan Johansen
Jun 13, 2013·Nature Reviews. Neuroscience·David J NuttDavid E Nichols
Aug 27, 2013·PloS One·Teri S Krebs, Pål-Ørjan Johansen
Jan 1, 2013·F1000Research·Teri S Krebs, Pål-Ørjan Johansen
Mar 20, 2014·Brain : a Journal of Neurology·Christoph J SchankinPeter J Goadsby
Jul 19, 2014·Behavioural Brain Research·Adam L Halberstadt
Aug 2, 2014·Therapeutic Advances in Psychopharmacology·David BaumeisterDerek Tracy
Sep 13, 2014·Journal of Psychopharmacology·Matthew W JohnsonRoland R Griffiths

❮ Previous
Next ❯

Citations

Nov 4, 2015·The International Journal on Drug Policy·Alex StevensHarry Sumnall
Jul 6, 2016·Frontiers in Human Neuroscience·Matthew M NourRobin L Carhart-Harris
Nov 5, 2016·Neuroscience and Biobehavioral Reviews·Rafael G Dos SantosJaime E C Hallak
Nov 26, 2016·International Journal of Molecular Sciences·Danilo De GregorioGabriella Gobbi
Sep 24, 2015·Journal of Psychopharmacology·Peter S HendricksRoland R Griffiths
Sep 24, 2015·Journal of Psychopharmacology·Ragnar NesvågPål-Ørjan Johansen
Nov 20, 2016·Journal of Psychopharmacology·Frederick S BarrettRoland R Griffiths
Nov 20, 2016·Journal of Psychopharmacology·James Jh RuckerAllan H Young
Apr 27, 2017·Journal of Psychoactive Drugs·Matthew M NourRobin L Carhart-Harris
Jun 21, 2017·Journal of Psychopharmacology·Matthias Forstmann, Christina Sagioglou
Jan 20, 2017·Therapeutic Advances in Psychopharmacology·Ananya Mahapatra, Rishi Gupta
May 22, 2018·The Journal of Nervous and Mental Disease·Brian S BarnettHarrison G Pope
Jun 26, 2018·Journal of Psychopharmacology·Clément E Lemercier, Devin B Terhune
Feb 16, 2018·Journal of Psychopharmacology·Robin L Carhart-HarrisMendel Kaelen
Jul 28, 2018·Journal of Psychoactive Drugs·Logan Neitzke-Spruill, Carol Glasser
Feb 7, 2019·PloS One·Vince Polito, Richard J Stevenson
Mar 7, 2019·Journal of Psychoactive Drugs·Ansgar Rougemont-BückingJoseph Studer
Feb 23, 2020·PloS One·Bheatrix BienemannDaniel C Mograbi
Jun 9, 2020·Journal of Psychoactive Drugs·Samuli KangaslampiTarina Rauteenmaa
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Jun 30, 2018·The Mental Health Clinician·Jeremy Daniel, Margaret Haberman
Jul 22, 2018·Frontiers in Pharmacology·Eduardo Ekman Schenberg
Jan 23, 2020·Proceedings of the National Academy of Sciences of the United States of America·Matthias ForstmannMolly J Crockett
Jul 20, 2016·Journal of Psychoactive Drugs·Mark HadenKenneth W Tupper
May 26, 2017·Therapeutic Advances in Psychopharmacology·Rafael G Dos SantosJaime E C Hallak
Oct 19, 2017·Journal of Psychopharmacology·Peter S HendricksGregory Pavela
Oct 17, 2019·Neuroscience of Consciousness·Andrew PetersonCharles Weijer
Feb 11, 2020·Frontiers in Psychiatry·Juan José FuentesMarta Torrens
Sep 24, 2019·Irish Journal of Psychological Medicine·J R KellyV O'Keane
Feb 27, 2020·The American Journal of Psychiatry·Collin M ReiffUNKNOWN the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research
May 22, 2020·Therapeutic Advances in Psychopharmacology·Matthew ButlerJames Rucker
Mar 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jakub Benko, Stanislava Vranková
Jan 31, 2021·Pharmacology, Biochemistry, and Behavior·M L Shawn Bates, Keith A Trujillo
Oct 31, 2020·Acta Psychiatrica Scandinavica·Kristoffer A A AndersenDavid Erritzoe
Dec 18, 2020·Pharmacological Reviews·Antonio InserraGabriella Gobbi
Mar 13, 2021·Risk Management and Healthcare Policy·Rafael Guimarães Dos SantosJaime E Hallak
Mar 16, 2021·Therapeutic Advances in Psychopharmacology·David M O'ShaughnessyFrances Quirk
Mar 16, 2021·Journal of Psychopharmacology·Otto SimonssonPeter S Hendricks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.